Vir Biotechnology
211 hedge funds and large institutions have $2.2B invested in Vir Biotechnology in 2022 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 75 increasing their positions, 56 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
3.5% more ownership
Funds ownership: 61.33% → 64.83% (+3.5%)
3% more funds holding
Funds holding: 204 → 211 (+7)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
211
Holding in Top 10
2
Calls
$11.6M
Puts
$6.66M
Top Buyers
| 1 | +$173M | |
| 2 | +$30.9M | |
| 3 | +$18.3M | |
| 4 |
Morgan Stanley
New York
|
+$11.4M |
| 5 |
Renaissance Technologies
New York
|
+$10.9M |
Top Sellers
| 1 | -$94.8M | |
| 2 | -$39M | |
| 3 | -$13.7M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$11.6M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$8.46M |